Left-sided primary tumors are associated with favorable prognosis in patients with KRAS codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: an analysis of the AIO KRK-0104 trial

PURPOSE: AIO KRK-0104 investigated first-line therapy of metastatic colorectal cancer (mCRC) with cetuximab, capecitabine and irinotecan versus cetuximab, capecitabine and oxaliplatin. This analysis investigated the impact of primary tumor location on outcome of patients. PATIENTS AND METHODS: Left-...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: von Einem, J. C., Heinemann, V., von Weikersthal, L. Fischer, Vehling-Kaiser, U., Stauch, M., Hass, H. G., Decker, T., Klein, S., Held, S., Jung, A., Kirchner, T., Haas, M., Holch, J., Michl, M., Aubele, P., Boeck, S., Schulz, C., Giessen, C., Stintzing, S., Modest, D. P.
Formato: Artigo
Idioma:Inglês
Publicado: Springer Berlin Heidelberg 2014
Assuntos:
Original Article – Clinical Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4131148/
https://ncbi.nlm.nih.gov/pubmed/24816724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00432-014-1678-3
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares